Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001104659-17-062430

Options or other derivatives

  • 10% owner bought 500,000 shares at $100.00 ($50,000,000)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Roivant Sciences Ltd. 10% owner 2017-10-16 Purchase · Series A Participating Convertible Preferred Shares +500,000 $100.00 $50,000,000 500,000 D: show line 1 in the form
Loading xslF345X03/a4.xml…